Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | UCK2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SLC4A11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | RASEF | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CXCR5 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
mRNA | CLPTM1L | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | FAM188B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | PRPF39 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SENP6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | FZD3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |